3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Breast Neoplasms
1
Basal Cell Carcinoma of the Head and Neck
1
Interventions
pembrolizumab
9
Nivolumab
5
epacadostat
2
Thiotepa
2
Nonlinear Optical Microscopy
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Filgrastim
2
Cytological Techniques
2
Cyclophosphamide
2
Biopsy, Fine-Needle
2
Biopsy
2
vocimagene amiretrorepvec
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
spartalizumab
1
sapanisertib
1
romidepsin
1
relatlimab
1
poly ICLC
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
motexafin gadolinium
1
larotrectinib
1
ipatasertib
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Tissue Banks
×
Head & Neck
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled